skip to Global Navigation Bar skip to main content

homeHome > About Us > Recruitment > News


News Content
Daewoong Pharmaceutical’s diabetes treatment, ‘DWP16001,’ approved for clinical test phase 2 in Korea.
Date 2019-05-31 Hit 1508
News List
Prev Daewoong Pharmaceutical’s ‘Urusa 300mg’ secured application to ‘prevention of gallbladder stones after gastrectomy’ for the first time in the world.
Next A global symposium pays attention to Nav 1.7 Chronic Pain Treatment, DWP17061.